These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27789547)

  • 1. Reversal of anticoagulation with four-factor prothrombin complex concentrate without concurrent vitamin K (phytonadione) for urgent surgery in a patient at moderate-to-high risk for thromboembolism.
    Farley TM; Andreas EM
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27789547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural warfarin reversal with prothrombin complex concentrate.
    Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
    Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
    Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
    J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
    Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
    Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of prothrombin complex concentrate.
    Di Fusco SA; Aspromonte N; Aquilani S; Mele L; Colivicchi F
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):184-8. PubMed ID: 25087295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of vitamin K antagonists prior to urgent surgery.
    Grobler C; Callum J; McCluskey SA
    Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
    Kuroski JE; Young S
    Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.
    Refaai MA; Goldstein JN; Lee ML; Durn BL; Milling TJ; Sarode R
    Transfusion; 2015 Nov; 55(11):2722-9. PubMed ID: 26135740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Continuous-Flow Left Ventricular Assist Devices: A Narrative Review.
    Jennings DL; Rimsans J; Connors JM
    ASAIO J; 2020 May; 66(5):482-488. PubMed ID: 31192853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation Reversal for Supratherapeutic International Normalized Ratio: A Teachable Moment.
    Tummalapalli SL; Qiu Y; Cho HJ
    JAMA Intern Med; 2017 Jun; 177(6):869-870. PubMed ID: 28418446
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
    Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
    Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
    Bauer KA
    Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative warfarin reversal for early hip fracture surgery.
    Moores TS; Beaven A; Cattell AE; Baker C; Roberts PJ
    J Orthop Surg (Hong Kong); 2015 Apr; 23(1):33-6. PubMed ID: 25920640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies.
    Cartmill M; Dolan G; Byrne JL; Byrne PO
    Br J Neurosurg; 2000 Oct; 14(5):458-61. PubMed ID: 11198768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.
    Joseph R; Burner J; Yates S; Strickland A; Tharpe W; Sarode R
    Transfusion; 2016 Apr; 56(4):799-807. PubMed ID: 26589481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.